Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 14,969 | 0 | 0 | 0 |
| Gross Profit | N/A | 14,969 | N/A | N/A | N/A |
| Operating Expenses | 23,390 | 24,349 | 18,286 | 16,914 | 19,988 |
| Operating Income | -23,390 | -9,380 | -18,286 | -16,914 | -19,988 |
| Interest Expense | 12 | 17 | 12 | 12 | 7 |
| Other Income | 2,814 | 1,265 | 1,348 | 1,369 | 1,885 |
| Pre-tax Income | -20,588 | -8,132 | -16,950 | -15,557 | -18,110 |
| Income Tax | 3 | -3 | -7 | -37 | -820 |
| Net Income Continuous | -20,591 | -8,129 | -16,943 | -15,520 | -17,290 |
| Minority Interests | -51 | -15 | -12 | -31 | 3 |
| Net Income | $-20,540 | $-8,114 | $-16,931 | $-15,489 | $-17,293 |
| EPS Basic Total Ops | -0.51 | -0.21 | -0.43 | -0.40 | -0.44 |
| EPS Basic Continuous Ops | -0.51 | -0.21 | -0.43 | -0.40 | -0.45 |
| EPS Diluted Total Ops | -0.51 | -0.21 | -0.43 | -0.40 | -0.44 |
| EPS Diluted Continuous Ops | -0.51 | -0.21 | -0.43 | -0.40 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.21 | -0.43 | N/A | N/A |
| EBITDA(a) | $-21,962 | $-7,905 | $-16,819 | $-15,484 | $-18,553 |